SCHEDULE 13G

Company

HALOZYME THERAPEUTICS, INC.

Filed

October 21, 2004

Accession Number

0001193125-04-175183

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →